The sleep study excluded nicotine use and enrolled volunteers with no recent cannabis exposure and very limited lifetime marijuana use. Its findings are not direct evidence about nightly CBD use in frequent cannabis consumers.
The exposure history was restrictive
Participants were nonsmokers, had taken no medications for at least three months and reported no marijuana use in the preceding year. None had used marijuana more than five times in their lives or ever used another illicit drug. People with sleep disorders and other specified clinical conditions were excluded.
The administered preparation was highly purified CBD without THC, compared with a corn-oil placebo. Prior exposure and product composition both matter when defining this population.
Do not assume tolerance was tested
This design did not compare frequent users with cannabis-naive people or measure how cannabinoid tolerance changed the sleep response. An inference that experienced users would necessarily respond more or less strongly would require additional evidence. The same is true of claims about withdrawal-related insomnia.
Preserve the clinical distinction
The null conventional sleep findings concern selected good sleepers after one dose. They do not establish an effect during cannabis withdrawal, chronic mixed-product use or treatment of an established sleep disorder. A report should state the use-history restrictions before borrowing this experiment to answer a different patient or forensic question.
Related reading: limits on proposed CBD mechanisms.
Research cited
Linares and colleagues (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. DOI: 10.3389/fphar.2018.00315.
Leave a Reply